质子泵抑制剂与肌肉不良药物反应:意大利药物警戒数据库的不比例性分析
该研究基于意大利国家药物警戒数据库1983年7月至2016年5月的274,108份自发报告,采用病例/非病例不比例性分析评估PPIs与肌肉ADRs的报告风险。调整年龄和性别后,PPIs肌肉ADRs的ROR为1.484(95%CI 1.204-1.829;p<0.001),横纹肌溶解ROR为0.621(95%CI 0.258-1.499)。PPIs-他汀组合未显示肌肉ADRs/横纹肌溶解的ROR增强。
要点
- PPIs与肌肉ADRs报告风险增加相关,ROR 1.484(95%CI 1.204-1.829)
- PPIs与横纹肌溶解单独无显著不比例报告,ROR 0.621
- PPIs-他汀组合未增加肌肉ADRs/横纹肌溶解报告风险
核心结论
- 该探索性研究提示PPIs类可能与肌肉ADRs报告相关,而非其他ADRs,且比任何非他汀药物更频繁。
- 结果需进一步研究证实。
研究设计与样本
- 不比例性分析(病例/非病例),使用意大利国家药物警戒数据库1983年7月至2016年5月的自发报告。
- 研究共纳入274,108份报告,计算报告比值比(ROR)及95%置信区间(CI)。
主要发现
- 调整年龄和性别后,PPIs肌肉ADRs的ROR为1.484(95%CI 1.204-1.829;p<0.001)。
- PPIs横纹肌溶解的ROR为0.621(95%CI 0.258-1.499)。
- 二次分析结果相似。
- 三次分析中,PPIs无论疑似或伴随,PPIs-横纹肌溶解组合显示潜在不比例报告(ROR 1.667,95%CI 1.173-2.369;p<0.01)。
- PPIs-他汀组合与单用他汀相比,肌肉ADRs/横纹肌溶解的ROR未增强。
局限性
- 本研究为探索性研究,结果需进一步研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Proton pump inhibitors (PPIs) have been implicated in the occurrence of moderate to severe myopathies in several case reports. AIM: This study was performed to assess the reporting risk of muscular adverse drug reactions (ADRs) associated with PPIs in the Italian National Network of Pharmacovigilance database. METHODS: A disproportionality analysis (case/non-case) was performed using spontaneous reports collected in the database between July 1983 and May 2016. Reporting odds ratio (ROR) and 95% confidence intervals (CIs) were calculated as a measure of disproportionality. In a secondary and tertiary analysis, we explored the association of PPIs with muscular ADRs after taking into account the masking effect of statins. Moreover, the possibility of an interaction between PPIs and statins, leading to the occurrence of muscular ADRs, was also tested. RESULTS: The study was carried out on 274,108 reports. The ROR of muscular ADRs for PPIs, adjusted for age and gender, was 1.484 (95% CI 1.204-1.829; p < 0.001), whereas the ROR for rhabdomyolysis was 0.621 (95% CI 0.258-1.499). Similar results were obtained in the secondary analysis. The tertiary analysis, where PPIs were considered regardless of whether their role was suspected or concomitant, showed a potential disproportionate reporting for the combination PPIs-rhabdomyolysis (ROR 1.667, 95% CI 1.173-2.369; p < 0.01). The PPIs-statins combination was not associated with an enhanced ROR of muscular ADRs/rhabdomyolysis compared with statins alone. CONCLUSIONS: This explorative study suggests that the class of PPIs could be involved in reports of muscular ADRs, rather than any other ADR, more frequently than any non-statin drug. Our results must be corroborated by further studies.
引用
- Capogrosso Sansone A, Convertino I, Galiulo MT, et al. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database. Drug Saf. 2017. PMID: 28681266. doi:10.1007/s40264-017-0564-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。